TSHA - CIK 0001806310
As of 2026-06-13, Taysha Gene Therapies, Inc. (TSHA) has a market capitalization of $1.64 B, making it the #2266 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-06-13 | $1.64 B |
| 2026-06-12 | $1.67 B |
| 2026-06-11 | $1.60 B |
| 2026-06-10 | $1.53 B |
| 2026-05-29 | $1.67 B |
| 2026-05-28 | $1.65 B |
| 2026-05-26 | $1.60 B |
| 2026-05-25 | $1.58 B |
| 2026-05-24 | $1.58 B |
| 2026-05-22 | $1.58 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-06-13, Taysha Gene Therapies, Inc. (TSHA) has a market capitalization of $1.64 B, making it the #2266 most valuable US-listed company.
Taysha Gene Therapies, Inc. is the #2266 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.